Episode 34: Antibody and Vaccine Development for COVID-19 – Panel Discussion

The Chain: Protein Engineering Podcast

Content provided by Cambridge Healthtech Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cambridge Healthtech Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

3y ago 40:56

MP3•Episode home

This episode of The Chain features a live panel discussion moderated by Erica Ollmann Saphire, PhD of La Jolla Institute for Immunology. Expert panelists from academia and government assess the COVID-19 antibody and vaccine development thus far, including what did and did not go well during the pandemic. They also look towards the future and the role mRNA vaccines may play for diseases like influenza, what we learned about the United States’ ability to manufacture during surge production, and what infrastructure is still needed to fight both the current crisis and future outbreaks.

Erica Ollmann Saphire, PhD, Professor, La Jolla Institute for Immunology
Peter Hotez, MD, PhD, FASTMH, FAAP, Dean, National School of Tropical Medicine; Professor, Departments of Pediatrics, Molecular Virology & Microbiology; Co-Head, Section of Pediatric Tropical Medicine; Health Policy Scholar, Baylor College of Medicine
Lakshmi Krishnan, PhD, Vice-President, Life Sciences, National Research Council Canada, Government of Canada
Peter W. Marks, MD, PhD, Director, FDA CBER

65 episodes

#Science #Biology #Cambridge Healthtech Institute #Proteins #Protein Engineering #Scientists #RD In #Antibodies #Bispecific Antibodies #Solid Tumors